VHL Vitasora Health Limited
Healthcare · Health Information Services
· website
$0.01
52wk 0.01 – 0.04
Overall
66.5
Value
86.0
Growth
100.0
Health
100.0
Quality
0.0
Momentum
17.6
Dividend
—
Price
About Vitasora Health Limited
Vitasora Health Limited engages in the research, development, and commercialization of medical devices in Australia and the United States. The company offers wheezo device. It is also involved in the production of mobile health applications. In addition, the company provides solutions for managing chronic diseases, including cardiovascular, diabetes, chronic obstructive pulmonary disease, and obesity. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia.
Price analytics
Returns
| 1 day | 0.0% |
| 1 week | 8.3% |
| 1 month | -13.3% |
| 3 months | 0.0% |
| 6 months | -35.0% |
| 1 year | -53.6% |
| 3 years | -63.9% |
Risk
| Volatility (1y ann.) | 116.4% |
| Beta vs ASX 200 | -0.02 |
| Sharpe (1y) | -0.12 |
| VaR 95% (1-day) | -9.1% |
| Max drawdown (1y) | -71.9% |
| Off 1-year high | -59.4% |
Technicals
| RSI(14) | 50 |
| vs 50DMA | 4.1% |
| vs 200DMA | -22.2% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
86.0
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
85
Price / Sales
40
Growth
100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
100
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
—
Quality (Profitability & Cash Flow)
0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
17.6
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
70
Position in 52-week range
13
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$30.53M
P/E (trailing)
—
P/E (forward)
-13.00
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
-0.35
EV / EBITDA
-2.92
Price / Book
1.86
ROE
-70.3%
Operating margin
-275.4%
Net margin
-219.2%
Total cash
$3.08M
Total debt
$0
Current ratio
2.90
Debt / Equity
—
Free cash flow
$-6.47M
Avg volume
1.49M
Latest annual results
(FY ending 30 Jun 2026)
- Revenue—
- Gross profit—
- Operating income—
- Net income—
- Diluted EPS-0.01
- Free cash flow—
- Net debt—